High-dose-rate interstitial brachytherapy for mucinous adenocarcinoma endocervical-type--a case study

Ginekol Pol. 2013 Dec;84(12):1059-63. doi: 10.17772/gp/1681.

Abstract

Background: Adenocarcinoma in cervical cancer has poorer response rate to treatment and requires longer time to achieve complete remission than squamous cell carcinoma [1]. Lower response to chemotherapy and radiotherapy is observed [2,3,4,5] and the optimal management remains undefined [1,4,6,7].

Case: We report a case of a 58-year-old woman with bulky mucinous adenocarcinoma endocervical-type G1, treated previously with radiochemotherapy with no visible response. After subsequent interstitial HDR brachytherapy (iHDR-BT) complete local remission was achieved.

Conclusion: Interstitial HDR brachytherapy in bulky mucinous adenocarcinoma endocervical-type may be the best treatment choice that allows to receive a complete local response.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma, Mucinous / radiotherapy*
  • Brachytherapy / methods*
  • Female
  • Humans
  • Middle Aged
  • Radiotherapy Dosage
  • Treatment Outcome
  • Uterine Cervical Neoplasms / radiotherapy*